AbbVie
ABBV
#27
Rank
HK$3.593 T
Marketcap
HK$2,034
Share price
0.95%
Change (1 day)
36.17%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): HK$46.65 Billion

According to AbbVie's latest financial reports the company's current earnings are HK$62.81 Billion. In 2025 the company made an earning of HK$51.72 Billion, an increase over its 2024 earnings that were of HK$29.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$46.65 B-9.8%
2025 HK$51.72 B77.53%
2024 HK$29.13 B-40.54%
2023 HK$49.00 B-53.62%
2022 HK$105.67 B3.76%
2021 HK$101.85 B282.25%
2020 HK$26.64 B-59.67%
2019 HK$66.07 B62.13%
2018 HK$40.75 B-32.74%
2017 HK$60.59 B-1.99%
2016 HK$61.82 B18.65%
2015 HK$52.10 B180.5%
2014 HK$18.57 B-55.57%
2013 HK$41.81 B-6.86%
2012 HK$44.89 B56.05%
2011 HK$28.76 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$83.04 B 77.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$244.06 B 420.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$71.25 B 52.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$12.72 B-72.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$84.12 B 79.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$75.25 B 60.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$114.98 B 145.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$78.50 B 67.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$6.26 B-86.63%๐Ÿ‡บ๐Ÿ‡ธ USA